Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NCT: NCT06511141 · RECRUITING

NCT IDNCT06511141

StatusRECRUITING

Start Date2024-10-22

SponsorAxonics, Inc. (INDUSTRY)

First posted2024-07-19

Last updated2026-10-13

Brief Summary

To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑